🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting products of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Response and Content Removal

According to TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Research also found groups with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with images of slimming results, glowing reviews and detailed instructions for preparing or administering at residence.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts display dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially serious health risks”.